CellSight Technologies, Inc.
11 clinical trials · Sponsor
◉ Watch CellSight Technologies, Inc.
| Record | Firm | Date |
|---|---|---|
| [18F]F-AraG PET Imaging in Alzheimer's Disease (NCT07611357) | CellSight Technologies, Inc. | 2026-05-16 |
| Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG (NCT06107374) | CellSight Technologies, Inc. | 2023-11-01 |
| Test-retest Evaluation of [18F]F-AraG PET (NCT06084806) | CellSight Technologies, Inc. | 2023-10-31 |
| A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors (NCT04260256) | CellSight Technologies, Inc. | 2022-03-01 |
| Imaging Immune Activation in COVID-19 (NCT04815096) | CellSight Technologies, Inc. | 2021-04-15 |
| Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer (NCT04726215) | CellSight Technologies, Inc. | 2021-04-15 |
| Imaging Immune Activation in HIV by PET-MR (NCT03684655) | CellSight Technologies, Inc. | 2018-09-21 |
| Detection of Graft Versus Host Disease With [18F]F-AraG (NCT03367962) | CellSight Technologies, Inc. | 2018-05-15 |
Track CellSight Technologies, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.